Company Filing History:
Years Active: 2016
Title: The Innovations of Stephen Su
Introduction
Stephen Su is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work is characterized by a focus on innovative solutions that address complex medical challenges.
Latest Patents
Stephen Su holds a patent for "ANTI-C-MET tandem Fc bispecific antibodies." This patent describes tandem Fcs and tandem Fc antibodies (TFcAs), which include one or more binding sites that specifically target cell surface receptors. The binding sites are connected through a TFc, which consists of a first Fc region and a second Fc region. These regions are linked via a TFc linker to form a contiguous polypeptide and dimerize to create an Fc dimer. Notably, the exemplary TFcBAs developed by Su bind to the cell surface receptors c-Met and EpCam, effectively inhibiting signal transduction through the targeted receptors.
Career Highlights
Stephen Su is currently employed at Merrimack Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative approach has led to the creation of groundbreaking therapies that have the potential to improve patient outcomes.
Collaborations
Stephen has collaborated with esteemed colleagues such as Brian Harms and Neeraj Kohli. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Stephen Su's contributions to the field of biotechnology, particularly through his patent on bispecific antibodies, highlight his role as an influential inventor. His work at Merrimack Pharmaceuticals, Inc. continues to pave the way for innovative medical solutions.